|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"jia horng kao"
Showing items 766-815 of 1180 (24 Page(s) Totally)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2018-09-10T18:03:51Z |
Quantification of serum hepatitis B core antibody to predict off-entecavir relapse in patients with chronic hepatitis B
|
Tseng, C.-H.;Hsu, Y.-C.;Chang, C.-Y.;Tseng, T.-C.;Wu, M.-S.;Lin, J.-T.;Kao, J.-H.; MING-SHIANG WU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:51Z |
Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy
|
Hsu, Y.-C.;Mo, L.-R.;Chang, C.-Y.;Wu, M.-S.;Yang, T.-H.;Kao, J.-H.;Chen, C.-C.;Tseng, C.-H.;Tai, C.-M.;Lin, C.-W.;Wu, C.-Y.;Lin, J.-T.; MING-SHIANG WU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:50Z |
Elimination of Hepatitis B: Is It a Mission Possible?
|
Jia-Horng Kao; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:50Z |
Elimination of Hepatitis B: Is It a Mission Possible?
|
Jia-Horng Kao; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:50Z |
Letter: the influence of direct acting agents for hepatitis C, on hepatitis B reactivation
|
Jia-Horng Kao; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:50Z |
Letter: the influence of direct acting agents for hepatitis C, on hepatitis B reactivation
|
Jia-Horng Kao; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:50Z |
Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants
|
Chih-Lin Lin;Jia-Horng Kao; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:50Z |
Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants
|
Chih-Lin Lin;Jia-Horng Kao; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:47Z |
Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma
|
Tseng, T.-C. and Liu, C.-J. and Su, T.-H. and Yang, W.-T. and Chen, C.-L. and Yang, H.-C. and Wang, C.-C. and Kuo, S.F.-T. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; TUNG-HUNG SU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:47Z |
Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection
|
Liu, C.-H. and Liu, C.-J. and Su, T.-H. and Fang, Y.-J. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; TUNG-HUNG SU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:46Z |
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection
|
Liu, C.-H.;Chen, Y.-S.;Wang, S.-S.;Liu, C.-J.;Su, T.-H.;Yang, H.-C.;Hong, C.-M.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; DING-SHINN CHEN; CHUN-MING HONG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:02:16Z |
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients
|
Lee, M.-H.;Huang, C.-F.;Lai, H.-C.;Lin, C.-Y.;Dai, C.-Y.;Liu, C.-J.;Wang, J.-H.;Huang, J.-F.;Su, W.-P.;Yang, H.-C.;Kee, K.-M.;Yeh, M.-L.;Chuang, P.-H.;Hsu, S.-J.;Huang, C.-I.;Kao, J.-T.;Chen, C.-C.;Chen, S.-H.;Jeng, W.-J.;Yang, H.-I.;Yuan, Y.;Lu, S.-N.;Sheen, I.-S.;Liu, C.-H.;Peng, C.-Y.;Kao, J.-H.;Yu, M.-L.;Chuang, W.-L.;Chen, C.-J.; HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:01:01Z |
Treatment of de novo hepatitis C virus-related fibrosing cholestatic hepatitis after orthotopic heart transplantation by ledipasvir and sofosbuvir.
|
Chen-Hua Liu;Yih-Sharng Chen;Sheoi-Shen Wang;Jia-Horng Kao; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:01:01Z |
Treatment of de novo hepatitis C virus-related fibrosing cholestatic hepatitis after orthotopic heart transplantation by ledipasvir and sofosbuvir.
|
Chen-Hua Liu;Yih-Sharng Chen;Sheoi-Shen Wang;Jia-Horng Kao; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:00:57Z |
High serum lipopolysaccharide-binding protein level in chronic hepatitis C viral infection is reduced by anti-viral treatments
|
Nien, H.-C. and Hsu, S.-J. and Su, T.-H. and Yang, P.-J. and Sheu, J.-C. and Wang, J.-T. and Chow, L.-P. and Chen, C.-L. and Kao, J.-H. and Yang, W.-S.; JIN-CHUAN SHEU; LU-PING CHOW; WEI-SHIUNG YANG; TUNG-HUNG SU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:00:57Z |
Telbivudine therapy for chronic hepatitis B: A journey to identify super-responders and to optimize treatment using the roadmap model
|
Kao, J.-H.;Asselah, T.;Dou, X.-G.;Hamed, K.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:00:55Z |
Benefits of long-term therapy with nucleos(t)ide analogues in treatment-naive patients with chronic hepatitis B
|
Wei, L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:37:36Z |
New perspectives of biomarkers for the management of chronic hepatitis B
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:36:55Z |
Liver gene expression profiles correlate with virus infection and response to interferon therapy in chronic hepatitis B patients
|
Tu, Hui-Chu; Liu, Chun-Jen; Liu, Chun-Jen; Wu, Hui-Lin;Hsiao, Tzu-Hung;Chen, Pei-Jer;Wong, Siao-Han;Kao, Jia-Horng;Chen, Ding-Shinn;Lu, Jo-Yang;Lu, Tzu-Pin;Chen, Yidong;Chuang, Eric Y.;Tu, Hui-Chu;Liu, Chun-Jen; Wu, Hui-Lin; Hsiao, Tzu-Hung; Chen, Pei-Jer; Wong, Siao-Han; Kao, Jia-Horng; Chen, Ding-Shinn; Lu, Jo-Yang; Lu, Tzu-Pin; Chen, Yidong; Chuang, Eric Y.; Tu, Hui-Chu; Liu, Chun-Jen; Wu, Hui-Lin;Hsiao, Tzu-Hung;Chen, Pei-Jer;Wong, Siao-Han;Kao, Jia-Horng;Chen, Ding-Shinn;Lu, Jo-Yang;Lu, Tzu-Pin;Chen, Yidong;Chuang, Eric Y.;Tu, Hui-Chu;Liu, Chun-Jen; Wu, H.-L. and Hsiao, T.-H. and Chen, P.-J. and Wong, S.-H. and Kao, J.-H. and Chen, D.-S. and Lu, J.-Y. and Lu, T.-P. and Chen, Y. and Chuang, E.Y. and Tu, H.-C. and Liu, C.-J.; 陳定信;高嘉宏;盧子彬;吳慧琳;劉俊人;陳培哲; 陳定信;高嘉宏;劉俊人;陳培哲; 戴槐青; 余宏政; T.-P. LU; Wu, Hui-Lin; Tai, Huai-Ching; CHUN-JEN LIU; Hsiao, Tzu-Hung; Chung, Shiu-Dong; Chen, Pei-Jer; Chien, Chiang-Ting; DING-SHINN CHEN; Chen, Pei-Jer; Chen, Pei-Jer; JIA-HORNG KAO; Wong, Siao-Han; Wong, Siao-Han; Yu, Hong-Jeng; Kao, Jia-Horng; Kao, Jia-Horng; Kao, Jia-Horng; Chen, Ding-Shinn; Lu, Jo-Yang; Lu, Jo-Yang; T.-P. LU; Lu, Tzu-Pin; T.-P. LU; Chen, Yidong; Chen, Yidong; Chuang, Eric Y. |
| 臺大學術典藏 |
2018-09-10T15:35:17Z |
Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.
|
Yang, Wan-Ting;Wu, Li-Wei;Tseng, Tai-Chung;Chen, Chi-Ling;Yang, Hung-Chih;Su, Tung-Hung;Wang, Chia-Chi;Kuo, Stephanie Fang-Tzu;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Liu, Chun-Jen;Kao, Jia-Horng; Wan-Ting Yang, Li-Wei Wu, Tai-Chung Tseng, Chi-Ling Chen, Hung-Chih Yang, Tung-Hung Su, Chia-Chi Wang, Stephanie Fang-Tzu Kuo, Chen-Hua Liu, Pei-Jer Chen, Ding-Shinn Chen, Chun-Jen Liu, Jia-Horng Kao; 劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳祈玲; HUNG-CHIH YANG; Yang, Wan-Ting; Wu, Li-Wei; CHUN-JEN LIU; Tseng, Tai-Chung; PEI-JER CHEN; Chen, Chi-Ling; CHEN-HUA LIU; DING-SHINN CHEN; Yang, Hung-Chih; TUNG-HUNG SU; Su, Tung-Hung; JIA-HORNG KAO; Wang, Chia-Chi; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:35:07Z |
Management of hepatitis C patients with decompensated liver disease
|
Hsu, Ching-Sheng;Kao, Jia-Horng; Hsu, Ching-Sheng; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:35:07Z |
More viral mutants, less HBsAg clearance? One size may not fit all
|
Tseng, T.-C.;Yang, H.-C.;Kao, J.-H.; HUNG-CHIH YANG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:35:07Z |
No Evidence of Reactivation of Hepatitis B Virus among Patients Treated with Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection
|
Sulkowski, M.S.;Chuang, W.-L.;Kao, J.-H.;Yang, J.C.;Gao, B.;Brainard, D.M.;Han, K.-H.;Gane, E.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:35:07Z |
Peginterferon Lambda-1a/ribavirin with daclatasvir or peginterferon alfa-2a/ribavirin with telaprevir for chronic hepatitis c genotype 1b
|
Flisiak, R.;Kawazoe, S.;Znoyko, O.;Assy, N.;Gadano, A.;Kao, J.-H.;Lee, K.-S.;Zwirtes, R.;Portsmouth, S.;Dong, Y.;Xu, D.;Kumada, H.;Srinivasan, S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:35:07Z |
Perspectives on dual hepatitis B and C infection in Taiwan
|
Liu, Chun-Jen; Liu, Chun-Jen; CHUN-JEN LIU; PEI-JER CHEN; Chen, Pei-Jer; Chen, Pei-Jer; DING-SHINN CHEN; Chen, Ding-Shinn; JIA-HORNG KAO; Tseng, Tai-Chung; Kao, Jia-Horng; Kao, Jia-Horng; Liu, Chun-Jen;Chen, Pei-Jer;Chen, Ding-Shinn;Tseng, Tai-Chung;Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:35:07Z |
Review article: novel therapies for hepatitis B virus cure – advances and perspectives
|
Lin, C.-L.;Kao, J.-H.; Lin, C. -L.; JIA-HORNG KAO; Lin, C. -L.; Kao, J. -H.; Kao, J. -H.; Chi, Yu-Chiao |
| 臺大學術典藏 |
2018-09-10T15:35:07Z |
Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis
|
Kao, Jia-Horng;Tung, Shui-Yi;Lee, Younjae;Thongsawat, Satawat;Tanwandee, Tawesak;Sheen, I. -Shyan;Wu, Jinzi J.;Li, Hui;Brennan, Barbara J.;Zhou, Julian;Le Pogam, Sophie;Najera, Isabel;Thommes, James A.;Hill, George; JIA-HORNG KAO; Kao, Jia-Horng; Tung, Shui-Yi; Lee, Younjae; Thongsawat, Satawat; Tanwandee, Tawesak; Sheen, I. -Shyan; Wu, Jinzi J.; Li, Hui; Brennan, Barbara J.; Zhou, Julian; Le Pogam, Sophie; Najera, Isabel; Thommes, James A.; Hill, George |
| 臺大學術典藏 |
2018-09-10T15:35:07Z |
以全民健康保險研究資料庫探討臺灣慢性C型肝炎患者之抗病毒藥物治療之利用
|
楊迥??賴翦·?高忥??; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:35:06Z |
Hepatitis C virus infection in Taiwan: Past, present, and future
|
Kao, Jia-Horng; JIA-HORNG KAO; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:35:06Z |
Hepatocellular carcinoma recurrence after interferon-free direct acting antiviral treatment for chronic hepatitis C virus infection: Fact or fiction?
|
Liu, Chen-Hua;Kao, Jia-Horng; Liu, Chen-Hua; CHEN-HUA LIU; JIA-HORNG KAO; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:35:06Z |
How have the recent advances in antiviral therapy impacted the management of virus-related hepatocellular carcinoma?
|
Wang, Chia-Chi;Kao, Jia-Horng; Wang, Chia-Chi; JIA-HORNG KAO; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:35:06Z |
Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus
|
Peng, Cheng-Yuan; Chen, Ting-Chih; Chang, Ting-Tsung; Lo, Gin-Ho; Tseng, Tai-Chung; Sheen, I-Shyan; Liu, Chen-Hua; Wang, Horng-Yuan; Su, Tung-Hung; Chen, Jyh-Jou; Chen, Pei-Jer; Chen, Ding-Shinn; Yang, Jenny C.; Liu, Chun-Jen; Knox, Steven J.; 陳定信; Gao, Bing; Garrison, Kimberly L.; 劉振驊; Mo, Hongmei; 吳慧琳; Pang, Phillip S.; Hsu, Yu-Chun; 蘇東弘; Hu, Tsung-Hui; 劉俊人; Chu, Chi-Jen; 陳培哲; Kao, Jia-Horng; CChuang, Wan-Long;Chien, Rong-Nan;Peng, Cheng-Yuan;Chang, Ting-Tsung;Lo, Gin-Ho;Sheen, I-Shyan;Wang, Horng-Yuan;Chen, Jyh-Jou;Yang, Jenny C.;Knox, Steven J.;Gao, Bing;Garrison, Kimberly L.;Mo, Hongmei;Pang, Phillip S.;Hsu, Yu-Chun;Hu, Tsung-Hui;Chu, Chi-Jen;Kao, Jia-Horng; Chuang, Wan-Long; JIA-HORNG KAO; Cheng, Huei-Ru; Kao, Jia-Horng; Chien, Rong-Nan; Wu, Hui-Lin |
| 臺大學術典藏 |
2018-09-10T15:35:06Z |
Looking into the crystal ball: biomarkers for outcomes of HBV infection
|
Yang, Hung-Chih;Kao, Jia-Horng; Yang, Hung-Chih; JIA-HORNG KAO; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:35:05Z |
Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection
|
Yang, Sheng-Shun;Kao, Jia-Horng; Yang, Sheng-Shun; Yang, Sheng-Shun; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:35:05Z |
Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: Pooled analysis of two phase 3 trials
|
Jensen, Donald M.;Asselah, Tank;Dieterich, Douglas;Foster, Graham R.;Sulkowski, Mark S.;Zeuzem, Stefan;Manny, Parvez;Yoshida, Eric M.;Moreno, Christophe;Ouzan, Denis;Wright, Mark;Morano, Luis E.;Buynak, Robert;Bourliere, Marc;Hassanein, Tarek;Nishiguchi, Shuhei;Kao, Jia-Horng;Omata, Masao;Paik, Seung W.;Wong, David K.;Tam, Edward;Kaita, Kelly;Feinman, S. Victor;Stern, Jerry O.;Scherer, Joseph;Quinson, Anne-Marie;Voss, Florian;Gallivan, John-Paul;Boecher, Wulf O.;Ferenci, Peter; JIA-HORNG KAO; Jensen, Donald M.; Asselah, Tank; Dieterich, Douglas; Foster, Graham R.; Sulkowski, Mark S.; Zeuzem, Stefan; Manny, Parvez; Yoshida, Eric M.; Moreno, Christophe; Ouzan, Denis; Wright, Mark; Morano, Luis E.; Buynak, Robert; Bourliere, Marc; Hassanein, Tarek; Nishiguchi, Shuhei; Kao, Jia-Horng; Omata, Masao; Paik, Seung W.; Wong, David K.; Tam, Edward; Kaita, Kelly; Feinman, S. Victor; Stern, Jerry O.; Scherer, Joseph; Quinson, Anne-Marie; Voss, Florian; Gallivan, John-Paul; Boecher, Wulf O.; Ferenci, Peter |
| 臺大學術典藏 |
2018-09-10T15:35:05Z |
HIV/HCV coinfection in Taiwan
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:35:05Z |
Hepatitis B virus: New therapeutic perspectives
|
Lin, Chih-Lin;Yang, Hung-Chih;Kao, Jia-Horng; JIA-HORNG KAO; Lin, Chih-Lin; Yang, Hung-Chih; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:35:04Z |
A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection
|
Chien, Rong-Nan; Chang, Ting-Tsung; Peng, Cheng-Yuan; Hu, Tsung-Hui; Lo, Gin-Ho; Wang, Horng-Yuan; Chen, Jyh-Jou; Yang, Jenny C.; Knox, Steven J.; Han, Lingling; Mo, Hongmei; Mathias, Anita; Brainard, Diana M.; Sheen, I-Shyan; Hsu, Yu-Chun; Chu, Chi-Jen; Chuang, Wan-Long; Chien, Rong-Nan; Chang, Ting-Tsung; Peng, Cheng-Yuan; Hu, Tsung-Hui; Lo, Gin-Ho; Wang, Horng-Yuan; Chen, Jyh-Jou; Yang, Jenny C.; Knox, Steven J.; Han, Lingling; Mo, Hongmei; Mathias, Anita; Brainard, Diana M.; Sheen, I-Shyan; Hsu, Yu-Chun; Chu, Chi-Jen; Chuang, Wan-Long; Kao, Jia-Horng; JIA-HORNG KAO; Ja-Ling Wu et al. |
| 臺大學術典藏 |
2018-09-10T15:35:04Z |
APASL consensus statements and recommendation on treatment of hepatitis C
|
Omata, M.;Kanda, T.;Wei, L.;Yu, M.-L.;Chuang, W.-L.;Ibrahim, A.;Lesmana, C.R.A.;Sollano, J.;Kumar, M.;Jindal, A.;Sharma, B.C.;Hamid, S.S.;Dokmeci, A.K.;Mamun-Al-Mahtab;Mccaughan, G.W.;Wasim, J.;Crawford, D.H.G.;Kao, J.-H.;Yokosuka, O.;Lau, G.K.K.;Sarin, S.K.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:35:04Z |
APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing
|
Omata, M.;Kanda, T.;Wei, L.;Yu, M.-L.;Chuang, W.-L.;Ibrahim, A.;Lesmana, C.R.A.;Sollano, J.;Kumar, M.;Jindal, A.;Sharma, B.C.;Hamid, S.S.;Dokmeci, A.K.;Al-Mahtab, M.;Mccaughan, G.W.;Wasim, J.;Crawford, D.H.G.;Kao, J.-H.;Yokosuka, O.;Lau, G.K.K.;Sarin, S.K.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:35:04Z |
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: A sub-analysis in Asian patients from the HALLMARK DUAL study
|
Kao, Jia-Horng;Lee, Youn-Jae;Heo, Jeong;Ahn, Sang-Hoon;Lim, Young-Suk;Peng, Cheng-Yuan;Chang, Ting-Tsung;Torbeyns, Anne;Hughes, Eric;Bhore, Rafia;Noviello, Stephanie; JIA-HORNG KAO; Kao, Jia-Horng; Lee, Youn-Jae; Heo, Jeong; Ahn, Sang-Hoon; Lim, Young-Suk; Peng, Cheng-Yuan; Chang, Ting-Tsung; Torbeyns, Anne; Hughes, Eric; Bhore, Rafia; Noviello, Stephanie |
| 臺大學術典藏 |
2018-09-10T15:35:04Z |
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
|
Chen, D. S.; Chen, H. L.; Chen, P. J.; Chien, R. N.; Chien, R. N.; Dokmeci, A. K.; Dokmeci, A. K.; Gane, Ed; Gane, Ed; Hou, J. L.; Jafri, W.; Jia, J.; Jia, J.; Kim, J. H.; Lai, C. L.; Lee, H. C.; Lee, H. C.; Lim, S. G.; Liu, C. J.; Locarnini, S.; Locarnini, S.; Al Mahtab, M.; Mohamed, R.; Omata, M.; Park, J.; Piratvisuth, T.; Sharma, B. C.; Sollano, J.; Wang, F. S.; Wei, L.; Yuen, M. F.; Yuen, M. F.; Zheng, S. S.; Kao, J. H.; Kao, J. H.; 陳培哲; Chen, C. J.; Chen, C. J.; Chan, H. L. Y.; JIA-HORNG KAO; Abbas, Z.; Lau, G. K.; Lau, G. K.; Kumar, M.; Sarin, S. K.; CHUN-JEN LIU; DING-SHINN CHEN; Sarin, S.K.;Kumar, M.;Lau, G.K.;Abbas, Z.;Chan, H.L.Y.;Chen, C.J.;Chen, D.S.;Chen, H.L.;Chen, P.J.;Chien, R.N.;Dokmeci, A.K.;Gane, E.;Hou, J.L.;Jafri, W.;Jia, J.;Kim, J.H.;Lai, C.L.;Lee, H.C.;Lim, S.G.;Liu, C.J.;Locarnini, S.;Al Mahtab, M.;Mohamed, R.;Omata, M.;Park, J.;Piratvisuth, T.;Sharma, B.C.;Sollano, J.;Wang, F.S.;Wei, L.;Yuen, M.F.;Zheng, S.S.;Kao, J.H. |
| 臺大學術典藏 |
2018-09-10T15:35:04Z |
Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg
|
Wang, Chia-Chi;Tseng, Kuo-Chih;Hsieh, Tsai-Yuan;Tseng, Tai-Chung;Lin, Hans Hsienhong;Kao, Jia-Horng; Wang, Chia-Chi; JIA-HORNG KAO; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Tseng, Tai-Chung; Lin, Hans Hsienhong; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:35:04Z |
Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: A pooled analysis
|
Kao, Jia-Horng;Jensen, Donald M.;Manns, Michael P.;Jacobson, Ira;Kumada, Hiromitsu;Toyota, Joji;Heo, Jeong;Yoffe, Boris;Sievert, William;Bessone, Fernando;Peng, Cheng-Yuan;Roberts, Stuart K.;Lee, Youn-Jae;Bhore, Rafia;Mendez, Patricia;Hughes, Eric;Noviello, Stephanie; JIA-HORNG KAO; Kao, Jia-Horng; Jensen, Donald M.; Manns, Michael P.; Jacobson, Ira; Kumada, Hiromitsu; Toyota, Joji; Heo, Jeong; Yoffe, Boris; Sievert, William; Bessone, Fernando; Peng, Cheng-Yuan; Roberts, Stuart K.; Lee, Youn-Jae; Bhore, Rafia; Mendez, Patricia; Hughes, Eric; Noviello, Stephanie |
| 臺大學術典藏 |
2018-09-10T15:35:03Z |
Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C
|
Yone-Han;Liu, Chen-Hua;Chen, Chi-Ling;Tseng, Tai-Chung;Liu, Chun-Jen;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Mah, Yone-Han; Mah, Yone-Han; CHUN-JEN LIU; Liu, Chen-Hua; Liu, Chen-Hua; CHEN-HUA LIU; Chen, Chi-Ling; DING-SHINN CHEN; JIA-HORNG KAO; Tseng, Tai-Chung; Tseng, Tai-Chung; Liu, Chun-Jen; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Kao, Jia-Horng; Kao, Jia-Horng; 陳祈玲 |
| 臺大學術典藏 |
2018-09-10T15:35:03Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients
|
Yao-Chun Hsu;Lein-Ray Mo;Chi-Yang Chang;Ming-Shiang Wu;Jia-Horng Kao;Wen-Lun Wang;Tzeng-Huey Yang;Chaur-Shine Wang;Ming-Feng Chiang;Chieh-Chang Chen;Yu-Jen Fang;Hsu-Wei Hung;Chun-Ying Wu;Jaw-Town Linhsu, Yao-Chun;Mo, Lein-Ray;Chang, Chi-Yang;Wu, Ming-Shiang;Kao, Jia-Horng;Wang, Wen-Lun;Yang, Tzeng-Huey;Wang, Chaur-Shine;Chiang, Ming-Feng;Chen, Chieh-Chang;Fang, Yu-Jen;Hung, Hsu-Wei;Wu, Chun-Ying;Lin, Jaw-Town; Hsu, Yao-Chun; MING-SHIANG WU; Mo, Lein-Ray; JIA-HORNG KAO; Chang, Chi-Yang; Wu, Ming-Shiang; Wu, Ming-Shiang; Kao, Jia-Horng; Kao, Jia-Horng; Wang, Wen-Lun; Wang, Wen-Lun; Yang, Tzeng-Huey; Yang, Tzeng-Huey; Wang, Chaur-Shine; Chiang, Ming-Feng; Chiang, Ming-Feng; Chen, Chieh-Chang; Chen, Chieh-Chang; Fang, Yu-Jen; Fang, Yu-Jen; Hung, Hsu-Wei; Hung, Hsu-Wei; Wu, Chun-Ying; Wu, Chun-Ying; Lin, Jaw-Town |
| 臺大學術典藏 |
2018-09-10T15:35:03Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients
|
Yao-Chun Hsu;Lein-Ray Mo;Chi-Yang Chang;Ming-Shiang Wu;Jia-Horng Kao;Wen-Lun Wang;Tzeng-Huey Yang;Chaur-Shine Wang;Ming-Feng Chiang;Chieh-Chang Chen;Yu-Jen Fang;Hsu-Wei Hung;Chun-Ying Wu;Jaw-Town Linhsu, Yao-Chun;Mo, Lein-Ray;Chang, Chi-Yang;Wu, Ming-Shiang;Kao, Jia-Horng;Wang, Wen-Lun;Yang, Tzeng-Huey;Wang, Chaur-Shine;Chiang, Ming-Feng;Chen, Chieh-Chang;Fang, Yu-Jen;Hung, Hsu-Wei;Wu, Chun-Ying;Lin, Jaw-Town; Hsu, Yao-Chun; MING-SHIANG WU; Mo, Lein-Ray; JIA-HORNG KAO; Chang, Chi-Yang; Wu, Ming-Shiang; Wu, Ming-Shiang; Kao, Jia-Horng; Kao, Jia-Horng; Wang, Wen-Lun; Wang, Wen-Lun; Yang, Tzeng-Huey; Yang, Tzeng-Huey; Wang, Chaur-Shine; Chiang, Ming-Feng; Chiang, Ming-Feng; Chen, Chieh-Chang; Chen, Chieh-Chang; Fang, Yu-Jen; Fang, Yu-Jen; Hung, Hsu-Wei; Hung, Hsu-Wei; Wu, Chun-Ying; Wu, Chun-Ying; Lin, Jaw-Town |
| 臺大學術典藏 |
2018-09-10T15:35:02Z |
Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model
|
Cheng, Huei-Ru; Jeng, Yung-Ming; JIA-HORNG KAO; Lin, Hsiu-Lin; Wang, Chih-Chiang; Kao, Jia-Horng; Chen, Pei-Jer; Chen, Ding-Shinn; Wu, Hui-Lin; TUNG-HUNG SU; Su, Tung-Hung; DING-SHINN CHEN; YUNG-MING JENG; Liu, Chun-Jen; Li, Yung-Tsung; CHUN-JEN LIU; 陳定信;高嘉宏;鄭永銘;吳慧琳;蘇東弘;劉俊人;陳培哲;林琇玲; Li, Y.-T. and Liu, C.-J. and Su, T.-H. and Cheng, H.-R. and Jeng, Y.-M. and Lin, H.-L. and Wang, C.-C. and Kao, J.-H. and Chen, P.-J. and Chen, D.-S. and Wu, H.-L.; Li, Yung-Tsung;Liu, Chun-Jen;Su, Tung-Hung;Cheng, Huei-Ru;Jeng, Yung-Ming;Lin, Hsiu-Lin;Wang, Chih-Chiang;Kao, Jia-Horng;Chen, Pei-Jer;Chen, Ding-Shinn;Wu, Hui-Lin; 陳定信;高嘉宏;鄭永銘;吳慧琳;蘇東弘;劉俊人;陳培哲;林琇玲 |
| 臺大學術典藏 |
2018-09-10T15:34:51Z |
Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway
|
Liu, Wei-Liang;Yang, Hung-Chih;Hsu, Ching-Sheng;Wang, Chih-Chiang;Wang, Tzu-San;Kao, Jia-Horng;Chen, Ding-Shinn; Liu, Wei-Liang; HUNG-CHIH YANG; DING-SHINN CHEN; Yang, Hung-Chih; Yang, Hung-Chih; JIA-HORNG KAO; Hsu, Ching-Sheng; Wang, Chih-Chiang; Wang, Chih-Chiang; Wang, Tzu-San; Wang, Tzu-San; Kao, Jia-Horng; Kao, Jia-Horng; Chen, Ding-Shinn |
| 臺大學術典藏 |
2018-09-10T15:34:51Z |
Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study
|
Chou, Shih-Wan; Liu, Chen-Hua; JIA-HORNG KAO; Liu, Chen-Hua; Yang, Hung-Chih; Yang, Hung-Chih; Wu, Shang-Ju; Wu, Shang-Ju; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Chen, Chi-Ling; Kao, Jia-Horng; Kao, Jia-Horng; 陳祈玲; Su, Tung-Hung;Liu, Chun-Jen;Tseng, Tai-Chung;Chou, Shih-Wan;Liu, Chen-Hua;Yang, Hung-Chih;Wu, Shang-Ju;Chen, Pei-Jer;Chen, Ding-Shinn;Chen, Chi-Ling;Kao, Jia-Horng; Su, T.-H. and Liu, C.-J. and Tseng, T.-C. and Chou, S.-W. and Liu, C.-H. and Yang, H.-C. and Wu, S.-J. and Chen, P.-J. and Chen, D.-S. and Chen, C.-L. and Kao, J.-H.; Su, Tung-Hung;Liu, Chun-Jen;Tseng, Tai-Chung;Chou, Shih-Wan;Liu, Chen-Hua;Yang, Hung-Chih;Wu, Shang-Ju;Chen, Pei-Jer;Chen, Ding-Shinn;Chen, Chi-Ling;Kao, Jia-Horng; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;吳尚儒;陳祈玲; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;吳尚儒;陳祈玲; Su, Tung-Hung; Su, Tung-Hung; CHUN-JEN LIU; Liu, Chun-Jen; CHEN-HUA LIU; Liu, Chun-Jen; Tseng, Tai-Chung; DING-SHINN CHEN; Chou, Shih-Wan; TUNG-HUNG SU |
Showing items 766-815 of 1180 (24 Page(s) Totally)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
View [10|25|50] records per page
|
